Provided by Tiger Fintech (Singapore) Pte. Ltd.

Durect

0.7382
-0.0075-1.01%
Volume:66.11K
Turnover:47.08K
Market Cap:22.92M
PE:-2.70
High:0.7382
Open:0.7200
Low:0.7000
Close:0.7457
Loading ...

Oppenheimer Sticks to Its Buy Rating for Durect (DRRX)

TIPRANKS
·
30 Mar

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation

Simply Wall St.
·
28 Mar

H.C. Wainwright Sticks to Its Hold Rating for Durect (DRRX)

TIPRANKS
·
27 Mar

Northland Securities Reaffirms Their Buy Rating on Durect (DRRX)

TIPRANKS
·
27 Mar

Q4 2024 DURECT Corp Earnings Call

Thomson Reuters StreetEvents
·
27 Mar

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges

GuruFocus.com
·
27 Mar

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Mar

DURECT Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

Durect: Q4 Earnings Snapshot

Associated Press Finance
·
27 Mar

Durect Q4 2024 GAAP EPS $0.24 Beats $(0.02) Estimate, Sales $500.000K Miss $6.907M Estimate

Benzinga
·
27 Mar

Durect reports Q4 cont ops EPS (6c), consensus (2c)

TIPRANKS
·
27 Mar

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

PR Newswire
·
27 Mar

DURECT Corp expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
25 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

Durect Corporation Announces Board Member’s Retirement

TIPRANKS
·
22 Feb

H.C. Wainwright Keeps Their Hold Rating on Durect (DRRX)

TIPRANKS
·
30 Jan

H.C. Wainwright views Durect as significant ‘going concern’ risk

TIPRANKS
·
30 Jan

Durect reports publication of Larsucosterol Phase 2b Results in NEJM Evidence

TIPRANKS
·
28 Jan

Durect (DRRX) Upgraded to Strong Buy: Here's Why

Zacks
·
17 Jan

Durect (DRRX) Upgraded to Buy: Here's What You Should Know

Zacks
·
12 Dec 2024